McKesson Renews Pharmaceutical Distribution Agreement with CVS Caremark

Thu Apr 25, 2013 7:00am EDT

* Reuters is not responsible for the content in this press release.

McKesson Renews Pharmaceutical Distribution Agreement with CVS Caremark

McKesson Corporation (NYSE: MCK) announced that is has renewed its current distribution agreement with CVS Caremark.

“We are extremely pleased to continue our long standing relationship with CVS Caremark,” said Paul Julian, executive vice president, group president, McKesson Corporation. “McKesson’s comprehensive supply chain solutions continue to help CVS Caremark ensure the highest levels of product availability and product integrity, empowering CVS Caremark to provide outstanding pharmaceutical care to its customers.”

About McKesson

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit http://www.mckesson.com.

McKesson Corporation
Erin Lampert, 415-983-8391 (Investors and Financial Media)
Erin.Lampert@McKesson.com
Kris Fortner, 415-983-8352 (General and Business Media)
Kris.Fortner@McKesson.com

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.